Inferior Oblique Muscle Anteriorization Versus Anteriorization and Resection in DVD With IOOA
Launched by KASR EL AINI HOSPITAL · Jul 31, 2023
Trial Information
Current as of August 19, 2025
Completed
Keywords
ClinConnect Summary
A prospective study was performed on patients with bilateral symmterical dissociated vertical deviation(DVD) and bilateral inferior oblique muscle overaction (IOOA) in Cairo University hospitals starting from February 2018 through December 2021. Patients wetre included in the study if they had a minimum follow up period of 6 months. The study included 54 patients (108 eyes) with manifest DVD and IOOA in boths eyes. Patients were divided into two equal groups. The paitents in group 1 underwent symmetrical inferior oblique muscle anteriorization, while the patients in group 2 underwent ayymme...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Manifest DVD decompensated to a tropia with free ocular motility
- • Cases with or without horizontal misalignment
- • Cases with or without previous horizontal muscle surgery
- Exclusion Criteria:
- • Incomitant, Paralytic or restrictive strabismus
- • Eyes with previous inferior oblique muscle surgery
- • Recurrent DVD after surgical treatment
- • Eyes with previous scleral buckling for retinal deatchment
About Kasr El Aini Hospital
Kasr El Aini Hospital, a prestigious medical institution affiliated with Cairo University, is dedicated to advancing healthcare through innovative clinical research. With a commitment to excellence, the hospital serves as a leading sponsor of clinical trials, leveraging its state-of-the-art facilities and a multidisciplinary team of healthcare professionals. The institution focuses on a diverse range of therapeutic areas, aiming to improve patient outcomes and contribute to the global medical community. By fostering collaboration and adhering to the highest ethical standards, Kasr El Aini Hospital plays a pivotal role in the development of new treatments and therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Trial Officials
Hala M. Elhiliali
Study Chair
Cairo University
Magda S. Abdel-Aziz
Study Director
Cairo University
Heba M. Fouad
Study Director
Cairo University
Ghada O. Mohamed
Principal Investigator
Cairo University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported